Clinical case use bevacizumab for patient with metastatic ovarian cancer

High incidence and mortality rate for ovarian cancer patients, short-term survival until relapse, repeated following surgeries and chemo- therapy, and also low survival rates make the problem of treatment of this pathology vital. Nowadays combination of platinum and paclitaxel (gemcitabine) in addit...

Full description

Bibliographic Details
Main Authors: M. R. Oganyan, O. V. Davidenko
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Opuholi Ženskoj Reproduktivnoj Sistemy
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/31